W
Wei Xie
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 35
Citations - 1206
Wei Xie is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: RNA & Biology. The author has an hindex of 15, co-authored 29 publications receiving 653 citations. Previous affiliations of Wei Xie include Chinese Academy of Sciences & Tianjin University.
Papers
More filters
Journal ArticleDOI
Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression
L. Lama,Carolina Adura,Wei Xie,Daisuke Tomita,Kamei Taku,Vitaly Kuryavyi,Tasos Gogakos,Joshua Steinberg,Michael Miller,Lavoisier Ramos-Espiritu,Asano Yasutomi,Hashizume Shogo,Aida Jumpei,Toshihiro Imaeda,Rei Okamoto,Andrew John Jennings,Mayako Michino,Takanobu Kuroita,Andrew Stamford,Pu Gao,Pu Gao,Peter T. Meinke,J. Fraser Glickman,Dinshaw J. Patel,Thomas Tuschl +24 more
TL;DR: The authors present small-molecule inhibitors of human cGAS, characterize their interaction with the protein, and show that the compounds are active in interferon-producing cells including primary human macrophages.
Journal ArticleDOI
Human cGAS catalytic domain has an additional DNA-binding interface that enhances enzymatic activity and liquid-phase condensation.
TL;DR: Factors that contribute to the enzymatic activity of the cGAS–cGAMP–STING pathway, a sentinel platform that senses the presence of foreign or mislocalized DNA in the cytoplasm, triggering innate immunity and interferon production are addressed.
Journal ArticleDOI
Structure and Functional Implications of the Human Rad9-Hus1-Rad1 Cell Cycle Checkpoint Complex
TL;DR: The crystal structure, together with biochemical assays, reveals that the interdomain connecting loops of hRad9, hHus1, and hRad1 are largely divergent, and further cocrystallization study indicates that a PCNA-interacting box (PIP box)-containing peptide derived from hFen1 binds tightly to the inter domain connecting loop of h Rad1, providing the molecular basis for the damage repair-specific activity of the 9-1-1 complex in
Journal ArticleDOI
N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.
Yuanming Cheng,Wei Xie,Brian F. Pickering,Karen L. Chu,Karen L. Chu,Angela M. Savino,Xuejing Yang,Hanzhi Luo,Diu Tt. Nguyen,Shanlan Mo,Ersilia Barin,Anthony Velleca,Thomas M. Rohwetter,Dinshaw J. Patel,Samie R. Jaffrey,Michael G. Kharas +15 more
TL;DR: This paper found that YTHDC1 is the essential reader in myeloid leukemia from a genome-wide CRISPR screen and that m6A is required for YTHdc1 to undergo liquid-liquid phase separation and form nuclear YTH DC1-m6A condensates (nYACs).
Journal ArticleDOI
Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
Gerard Minuesa,Steven K. Albanese,Wei Xie,Yaniv Kazansky,Daniel Worroll,Arthur Chow,Alexandra Schurer,Sun Mi Park,Christina Z. Rotsides,James Taggart,Andrea Rizzi,Andrea Rizzi,Levi N. Naden,Timothy Chou,Saroj Gourkanti,Daniel Cappel,Maria C. Passarelli,Maria C. Passarelli,Lauren Fairchild,Lauren Fairchild,Carolina Adura,Fraser Glickman,Jessica Schulman,Christopher Famulare,Minal Patel,Joseph K. Eibl,Gregory M. Ross,Shibani Bhattacharya,Derek S. Tan,Christina S. Leslie,Thijs Beuming,Dinshaw J. Patel,Yehuda Goldgur,John D. Chodera,Michael G. Kharas +34 more
TL;DR: This study finds that the small molecule Ro 08–2750 (Ro) binds directly and selectively to MSI2 and competes for its RNA binding in biochemical assays and provides a framework for targeting RNA binding proteins in cancer.